A Rare Disease That Can Look Like a Brain Tumor
Original title: Central Nervous System Manifestations of Rosai-Dorfman Disease: A Case Series.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is a report on three real patients, not a study testing a treatment.
The short version
Three people had a rare disease that looked like a brain tumor on their scans.
What was studied. Doctors reported three people with Rosai-Dorfman disease that affected the brain, the spine, or the base of the skull. They looked at each person's symptoms, scans, and tissue samples.
What they found. The three people were a 30-year-old woman with swelling of the tough covering around the brain and spine, a 66-year-old man with a growth at the base of the skull, and a 45-year-old man with face pain from a growth deep in the skull. In every case, doctors could only be sure of the diagnosis after surgery, when the tissue was checked in the lab. The tissue showed the pattern and markers that point to this disease.
What this means, and what it doesn't
What it could mean: This disease can look like a meningioma or like swelling from inflammation. Scans alone may not tell the difference. A tissue sample taken during surgery may be needed to know for sure. In these cases, surgery was used to take pressure off and to make the diagnosis. Some people also got steroids and chemotherapy. The doctors say care works best when several kinds of specialists work together.
What it doesn't mean: This is a report on three patients. It is not a study that tested a treatment. Nothing here was compared against another approach, so it cannot tell you what works best. It does not say how often this happens or what to expect long term. It is not a new treatment, and it is not a cure. It is a reminder to doctors to keep this rare disease in mind.
Source: PubMed, July 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.